<link rel="stylesheet" href="styles.cf390c6bfbe7555f.css"> Skip to main content

A novel compound PT-262 inhibits Oct4 and Nanog on the survivin blockage and apoptosis induction in human lung cancer

dc.citation.issue1en_US
dc.citation.volume30en_US
dc.contributor.authorChen, Yan-Tingen_US
dc.contributor.authorLi, Jing-Yien_US
dc.contributor.authorPan, Pei-Yingen_US
dc.contributor.authorChen, Chin-Piaoen_US
dc.contributor.authorChao, Jui-Ien_US
dc.contributor.department生物科技學系zh_TW
dc.contributor.department生物資訊及系統生物研究所zh_TW
dc.contributor.department分子醫學與生物工程研究所zh_TW
dc.contributor.departmentDepartment of Biological Science and Technologyen_US
dc.contributor.departmentInstitude of Bioinformatics and Systems Biologyen_US
dc.contributor.departmentInstitute of Molecular Medicine and Bioengineeringen_US
dc.date.accessioned2018-08-21T05:54:21Z
dc.date.available2018-08-21T05:54:21Z
dc.date.issued2016-04-01en_US
dc.identifier.issn0892-6638en_US
dc.identifier.journalFASEB JOURNALen_US
dc.identifier.urihttps://ir.lib.nycu.edu.tw/handle/11536/145849
dc.identifier.wosnumberWOS:000406444005526en_US
dc.language.isoen_USen_US
dc.titleA novel compound PT-262 inhibits Oct4 and Nanog on the survivin blockage and apoptosis induction in human lung canceren_US
dc.typeArticleen_US

Files

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description: